Jason Pitts

Jason Pitts

Plus aucun poste en cours
40 ans
Health Technology
Finance
Commercial Services

Profil

Jason Pitts is currently an Independent Director at Seaport Therapeutics, Inc. since 2024 and a Principal at General Atlantic LLC since 2021.
Former roles include Director at Bolt Biotherapeutics, Inc. from 2020 to 2021, Director at CinCor Pharma, Inc. from 2021 to 2023, Director at Third Harmonic Bio, Inc., Principal at Sofinnova Investments, Inc. from 2019 to 2021, Associate at McKinsey & Co., Inc. from 2016 to 2018, and Consultant at Solution Lab, Inc. in 2013.
Education includes undergraduate studies at Cornell University and a doctorate from The Rockefeller University.

Postes actifs de Jason Pitts

SociétésPosteDébut
Private Equity Investor 01/03/2021

Anciens postes connus de Jason Pitts

SociétésPosteFin
CINCOR PHARMA, INC. Directeur/Membre du Conseil 24/02/2023
Analyste en capital-investissement 01/01/2021
BOLT BIOTHERAPEUTICS, INC. Directeur/Membre du Conseil 01/01/2021
Corporate Officer/Principal 01/01/2018
Consultant / Advisor 01/12/2013
Voir l'expérience en détail de Jason Pitts

Formation de Jason Pitts

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

43

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Finance

Finance

Commercial Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Bourse
  2. Insiders
  3. Jason Pitts